Skip to content
6-K

Foreign Interim / Material

Jin Medical International Ltd. ZJYL

0001213900-25-079036

← back to feed
Filed
Aug 20, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Diluted Q2 2025 · Mar 31, 2025 156.55M sh
Shares Diluted Q2 2025 · Mar 31, 2024 156.4M sh
Capex Q2 2025 · Mar 31, 2025 $2.05M
Capex Q2 2025 · Mar 31, 2024 $83.68K
Operating Cash Flow Q2 2025 · Mar 31, 2025 $2.56M
Operating Cash Flow Q2 2025 · Mar 31, 2024 $50K
Short Term Debt Q2 2025 · Mar 31, 2025 $15.73M
Short Term Debt Q2 2025 · Sep 30, 2024 $11.32M
Short Term Investments Q2 2025 · Mar 31, 2025 $19.82M
Short Term Investments Q2 2025 · Sep 30, 2024 $18.62M
Stockholders Equity Q2 2025 · Mar 31, 2025 $27.91M
Stockholders Equity Q2 2025 · Sep 30, 2024 $28.82M
Current Liabilities Q2 2025 · Mar 31, 2025 $20.74M
Current Liabilities Q2 2025 · Sep 30, 2024 $17.15M
Total Liabilities Q2 2025 · Mar 31, 2025 $20.77M
Total Liabilities Q2 2025 · Sep 30, 2024 $17.25M
Current Assets Q2 2025 · Mar 31, 2025 $43.78M
Current Assets Q2 2025 · Sep 30, 2024 $42.82M
Total Assets Q2 2025 · Mar 31, 2025 $48.52M
Total Assets Q2 2025 · Sep 30, 2024 $45.8M
Eps Diluted Q2 2025 · Mar 31, 2025 $0.00
Eps Diluted Q2 2025 · Mar 31, 2024 $0.01
Eps Basic Q2 2025 · Mar 31, 2025 $0.00
Eps Basic Q2 2025 · Mar 31, 2024 $0.01
Sga Expense Q2 2025 · Mar 31, 2025 $1.45M
Sga Expense Q2 2025 · Mar 31, 2024 $1.54M
Rd Expense Q2 2025 · Mar 31, 2025 $660.89K
Rd Expense Q2 2025 · Mar 31, 2024 $609.65K
Net Income Q2 2025 · Mar 31, 2025 −$89.01K
Net Income Q2 2025 · Mar 31, 2024 $1.79M
Operating Income Q2 2025 · Mar 31, 2025 −$454.21K
Operating Income Q2 2025 · Mar 31, 2024 $1.23M
Gross Profit Q2 2025 · Mar 31, 2025 $2.4M
Gross Profit Q2 2025 · Mar 31, 2024 $3.74M
Cost Of Revenue Q2 2025 · Mar 31, 2025 $7.48M
Cost Of Revenue Q2 2025 · Mar 31, 2024 $6.82M
Revenue Q2 2025 · Mar 31, 2025 $9.88M
Revenue Q2 2025 · Mar 31, 2024 $10.56M